Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach

Retina

Volumn 24, Issue 3, 2004, Pages 376-382

  El Bradey, Mohamed H ^a   Cheng, Lingyun ^a   Song, Mi Kyoung ^a   Torriani, Francesca J ^b   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytomegalovirus retinitis; Epiretinal membrane; Human immunodeficiency virus; Macular edema; Uveitis

Indexed keywords

CIDOFOVIR; CORTICOSTEROID; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; EPIRETINAL MEMBRANE; FEMALE; GLAUCOMA; HUMAN; IMMUNE RESPONSE; LONG TERM CARE; MALE; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; SIDE EFFECT; STEROID THERAPY; UVEITIS; VIRUS REACTIVATION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; COMBINED MODALITY THERAPY; CYTOMEGALOVIRUS RETINITIS; EPIRETINAL MEMBRANE; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA, CYSTOID; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROGNOSIS; UVEITIS; VITRECTOMY; VITREOUS BODY;

EID: 2942635644     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200406000-00007     Document Type: Article

References (19)

1. Kupperman BD, Petty JG, Richman DD, et al. Correlation between CD4 counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus related non-infectious retinal vasculopathy in patients with acquired immune deficiency syndrome. Am J Ophthalmol 1993;115:575-582.
2. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996;114:821-827.
3. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107:75-80.
4. Karavallas MP, Lowder CY, Macdonald JC, et al. Immune recovery uveitis associated with inactive cytomegalovirus retinitis. Arch Ophthalmol 1998;116:169-175.
5. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998;125:292-300.
6. Karavellas MP, Plummer DJ, Macdonald JC, et al. Incidence of immune recovery uveitis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 1999;179:697-700.
7. Canzano JC, Reed JB, Morse LS. Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis. Retina 1998;18:443-447.
8. Nelson MR, Erskine D, Hawkins DA, et al. Treatment with corticosteroids: a risk factor for the development of clinical CMV disease in AIDS. AIDS 1993;7:375-378.
9. Henderson HWA, Mitchell SM. Treatment of immune recovery uveitis with local steroids. Br J Ophthalmol 1999;83:540-545.
10. Karavellas MP, Azen SP, Macdonald C, et al. Immune recovery uveitis and uveitis in AIDS: clinical predictors, sequelae and treatment outcomes. Retina 2001;21:1-9.
11. Nussenblatt RB, Palestine AG, Chan CC, Roberg F. Standardization of vitreal inflammatory activity in intermediate & posterior uveitis. Ophthalmology 1985;92:467-471.
12. Weizz JM, Bressler NM, Bressler SB, et al. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Ophthalmology 1999;106:1656-1659.
13. Whitcup SM. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA 2000;283:653-657.
14. Mutimer HP, Akatsuka Y, Manley T, et al. Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J Infect Dis 2002;186:701-705.
15. Nguyen QD, Kempen JH, Bolton SG, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000;129:634-639.
16. Kupperman BD, Holland GN. Immune recovery uveitis [editorial]. Am J Ophthalmol 2000;130:103-106.
17. Jabs DA, Van Natta ML, Kempen JH, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002;133:48-61.
18. Karavellas MP, Song M, Macdonald JC, Freeman WR. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol 2000;130:57-64.
19. Dunn JP. Immune recovery uveitis. Hopkins HIV Rep 2001;13:9-10.